NCT02029872View on ClinicalTrials.gov

Stop Community MRSA Colonization Among Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
MRSA
Interventions
DRUG

Chlorhexidine gluconate soap

4% chlorhexidine gluconate (soap)

DRUG

Chlorhexidine gluconate oral rinse

chlorhexidine gluconate oral rinse 0.12%

DRUG

Mupirocin calcium 2 % ointment

nasal mupirocin calcium 2% ointment

Trial Locations (1)

21287

Johns Hopkins Hospital, Baltimore

All Listed Sponsors
collaborator

Robert Wood Johnson Foundation

OTHER

lead

Johns Hopkins University

OTHER

NCT02029872 - Stop Community MRSA Colonization Among Patients | Biotech Hunter | Biotech Hunter